News

Understanding Core Scientific's Rising Options Enthusiasm

Understanding Core Scientific's Rising Options Enthusiasm

Core Scientific's Options Market Overview

Recently, significant interest has emerged among high-profile investors surrounding Core Scientific. This article delves into the dynamics of the options market as it relates to this promising company.

When we analyze the options trading activity for Core Scientific CORZ, it becomes clear that investors are expressing optimism. Among the recorded trades, a notable 66% were executed with bullish expectations, while 22% were bearish.

Specifically, examining the options trading reveals that out of 9 trades detected, there were 5 puts amounting to $389,858 and 4 calls totaling $220,767, indicating varied strategies at play.

Analyzing Price Targets

Upon reviewing trading volumes and Open Interest, it's evident that major market stakeholders are eyeing a price range for Core Scientific between $7.0 and $14.0. This span reflects market sentiment and trading strategies observed over the last three months.

Volume and Open Interest Insights

To gain a deeper understanding of options trading, monitoring volume and open interest is essential. Such data sheds light on the liquidity and interest levels for Core Scientific’s options activity relating to specific strike prices.

Within the last 30 days, the evolution of the volume and open interest for calls and puts yields meaningful insights into how whale traders are interacting with the stock within a strike price corridor from $7.0 to $14.0.

Snapshot of Core Scientific's 30-Day Option Activity

Highlights of Notable Options Trades

Several significant trades have been recorded, further solidifying the bullish sentiment among traders:

Details on Options Trades:

1. Symbol: CORZ, Type: PUT, Sentiment: Bullish, Expiration Date: 03/07/25, Total Trade Price: $165.5K, Volume: 4.0K.

2. Symbol: CORZ, Type: CALL, Sentiment: Bullish, Expiration Date: 04/17/25, Total Trade Price: $113.7K, Volume: 1.3K.

3. Symbol: CORZ, Type: PUT, Sentiment: Bullish, Expiration Date: 04/17/25, Total Trade Price: $63.3K, Volume: 374.

4. Symbol: CORZ, Type: PUT, Sentiment: Neutral, Expiration Date: 03/21/25, Total Trade Price: $60.7K, Volume: 973.

5. Symbol: CORZ, Type: PUT, Sentiment: Bearish, Expiration Date: 04/17/25, Total Trade Price: $58.0K, Volume: 0.

Core Scientific: Company Overview

Core Scientific Inc is a significant player in Blockchain and AI infrastructure. The company provides digital asset self-mining solutions, premium hosting, and various related services. Core Scientific operates through two segments: Equipment Sales, focused on blockchain infrastructure and third-party hosting, and a Mining segment, concentrating on digital asset mining for its benefit.

The blockchain sector's revenue is generated from the sale of consumption-based contracts and offering hosting services, while the mining sector earns revenue through processing transactions on blockchain networks, receiving digital currency assets in return.

Let’s take a closer look at Core Scientific’s current market standing to provide further context.

Current Market Position of Core Scientific

  • Currently, the stock is registering a volume of 4,390,511 with a price increase of 1.26%, sitting at $10.85.
  • Relative Strength Index (RSI) indicators show that the stock is neutral, neither overbought nor oversold.
  • An earnings report is anticipated in 68 days, a time frame that may influence trading strategies.

Analyst Perspectives on Core Scientific

Recent opinions from professional analysts provide valuable context for those interested in Core Scientific. The consensus target price stands at $18.4 based on evaluations from 5 market experts.

Highlighted ratings include:

  • Analyst from Cantor Fitzgerald maintains an Overweight rating with a target price of $21.
  • Needham remains positive, with a Buy rating and a price target of $17.
  • Compass Point upholds a Buy rating, targeting $20.
  • Though revised down, an analyst from HC Wainwright & Co. has adjusted their target to $17.
  • Canaccord Genuity stays consistent with a Buy rating and a target of $17.

Engaging in options trading carries inherent risks but can result in substantial rewards. Experienced traders manage these risks by emphasizing continuous learning, strategic adjustments, and leveraging various analytical tools and insights into market trends. Stay informed about Core Scientific’s options trading activity for the latest developments.

Frequently Asked Questions

What is Core Scientific's stock ticker?

Core Scientific's stock ticker is CORZ.

What has been the recent performance of Core Scientific?

Core Scientific has shown positive trends, with the stock price up by 1.26% recently.

What are analysts saying about Core Scientific?

The consensus among analysts is a target price of $18.4, with several recommending a Buy rating.

How does options trading work for Core Scientific?

Options trading involves purchasing calls or puts to speculate on price movements, with many recent trades suggesting bullish sentiment for Core Scientific.

What influences Core Scientific’s stock price?

Factors such as market dynamics, earnings reports, and analyst ratings significantly impact Core Scientific’s stock price.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Gemmy's Holiday Lights: Bright Ideas for 2026

Updated Category News Views 149

Deep in the heart of Dallas, Gemmy Industries is out to sprinkle a bit of magic over the holiday season for 2026. This ain't your grandma's string lights we're talkin' about here. We're diving headfirst into a new world of seasonal decor with tech-driven lights that look like they came straight outta a winter wonderland. And hey, if Walmart's set to host this lineup, you...

Continue Reading
IM Cannabis's Third Quarter Financial Jolt

Updated Category News Views 143

IM Cannabis Takes a Hit, But Seeks New Angles Diving into IM Cannabis's (NASDAQ: IMCC) latest financial splash is like reading a weathered old map of the stock market. The third quarter of 2026 wasn't kind to this little cannabis outfit. Revenues have nosedived to C$1.65 million from last year's C$5.08 million. It's not just the typical bad quarter blues; it's a solid...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 132

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 177

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Chime Joins S&P MidCap 400 Amid Merger Jostle

Updated Category News Views 194

Index Shake-Up: Who's In, Who's Out? Hold onto your hats, folks—big changes are coming to the S&P MidCap 400! Chime Financial Inc. is crashing the party, taking a seat at the table, as NorthWestern Energy Group gets the boot. Now, if that doesn’t grab your attention, I don’t know what will. You've got to appreciate the chaos and opportunities that come with a roster...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 81

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 150

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 53

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
55 Broad Street's New Face: A $500M Revamp with RXR

Updated Category News Views 189

Recapitalization: Changing the Game for 55 Broad Street Here we are again, watching yet another iconic Manhattan building redefine itself. This time, it's 55 Broad Street's turn, as Silverstein, MetroLoft, and RXR shake things up. Newmark Group, Inc. (NASDAQ: NMRK), the fiery real estate power player, orchestrated a dynamic transaction involving a $305 million financing...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 107

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading

Top 5 Most Recently Viewed Articles

Padlock Euro Storage Fund I Unveils Fourth-Quarter Distributions

Updated Category News Views 171

Padlock Euro Storage Fund I Distributions for Q4 2024 Padlock Euro Storage Fund I has recently shared good news for its unitholders regarding the cash distribution for the fourth quarter of the calendar year. The board of Trustees has officially approved these distributions, which reflect the Trust’s performance and commitment to its investors. Distribution Details The...

Continue Reading
Deer Park Road Seizes Opportunities Amid Commercial Real Estate Shift

Updated Category News Views 264

Deer Park Road's Strategic Focus on the CRE Market Deer Park Road Management Company, with a robust portfolio of $2.8 billion in alternative asset management, is navigating the turbulent waters of the commercial real estate (CRE) market. While challenges persist, especially in the Commercial Mortgage-Backed Securities (CMBS) sector, the firm sees compelling opportunities...

Continue Reading
MCB Real Estate's Rejection of Whitestone Offer Sparks Debate

Updated Category News Views 76

MCB Real Estate's Proposal Overview MCB Real Estate, a well-known developer in the commercial real estate sector, has made headlines recently with its acquisition proposal for Whitestone REIT. The proposed buyout included a cash offer of $15.00 per share, aimed at delivering a substantial premium to shareholders. MCB highlighted that this offer represented a 14.5%...

Continue Reading
Year-End Cash Dividend Announced for Mexico Equity Fund

Updated Category News Views 111

Year-End Cash Dividend Announced for Mexico Equity Fund The Mexico Equity and Income Fund, Inc. has recently set an exciting precedent for its shareholders by declaring a year-end cash dividend. This decision, made by the Fund’s Board of Directors, reflects a commitment to delivering value and returns to its investors. Details of the Cash Dividend The announced dividend...

Continue Reading
Emerging Trends in Altcoins: Navigating the Crypto Landscape

Updated Category News Views 168

Rising Speculation in Altcoins: An Overview Recent activities in the altcoin sector indicate a significant increase in leveraged positions, particularly with Ethereum and other notable altcoins. This surge has raised eyebrows in the crypto community, as analysts caution about potential fragility within the market, even as Bitcoin shows signs of relative stability....

Continue Reading